Insulin 100
2021 marks 100 years since the discovery of insulin. In conjunction with the University of Toronto, Diabetologia has commissioned reviews from leaders in the field to commemorate this landmark. Register for free for the University of Toronto’s Scientific Symposium here.
Consequences of recurrent hypoglycaemia on brain function in diabetes - published online 18/03/2021
Rory J. McCrimmon
Celebrating 100 years of insulin - published online 17/03/2021
Sally M. Marshall
Defining the underlying defect in insulin action in type 2 diabetes - published online 17/03/2021
Thiago M. Batista, Nida Haider & C. Ronald Kahn
‘Smart’ insulin-delivery technologies and intrinsic glucose-responsive insulin analogues - published online 12/03/2021
Mark A. Jarosinski, Balamurugan Dhayalan, Nischay Rege, Deepak Chatterjee & Michael A. Weiss
Current and future therapies for type 1 diabetes - published online 17/02/2021
Bernt Johan von Scholten, Frederik F. Kreiner, Stephen C. L. Gough & Matthias von Herrath
The consequences of hypoglycaemia - published online 07/02/2021
Stephanie A. Amiel
Realising the long-term promise of insulin therapy: the DCCT/EDIC study - published online 06/02/2021
David M. Nathan
Transforming type 1 diabetes: the next wave of innovation - published online 06/02/2021
Daniel J. Drucker
New closed-loop insulin systems - published online 06/02/2021
Charlotte K. Boughton & Roman Hovorka
Hypothalamic glucose-sensing mechanisms - published online 05/02/2021
Nal Ae Yoon & Sabrina Diano
The discovery of insulin in Toronto: beginning a 100 year journey of research and clinical achievement - published online 25/01/2021
Michael Fralick & Bernard Zinman
A global perspective on the issue of access to insulin - published online 23/01/2021
David Beran, Maria Lazo-Porras, Camille M. Mba & Jean Claude Mbanya
The promise of stem cell-derived islet replacement therapy - published online 16/01/2021
Douglas Melton